IN2014CN02870A - - Google Patents
Info
- Publication number
- IN2014CN02870A IN2014CN02870A IN2870CHN2014A IN2014CN02870A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A IN 2870CHN2014 A IN2870CHN2014 A IN 2870CHN2014A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A
- Authority
- IN
- India
- Prior art keywords
- proteins
- relates
- kits used
- diagnosis
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/34—Introducing sulfur atoms or sulfur-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1159348A FR2981352B1 (fr) | 2011-10-17 | 2011-10-17 | Procede de synthese de proteines |
| PCT/EP2012/070454 WO2013057084A1 (fr) | 2011-10-17 | 2012-10-16 | Procede de synthese de proteines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02870A true IN2014CN02870A (enExample) | 2015-07-03 |
Family
ID=47022687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2870CHN2014 IN2014CN02870A (enExample) | 2011-10-17 | 2012-10-16 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9206224B2 (enExample) |
| EP (1) | EP2768842B1 (enExample) |
| JP (1) | JP6321542B2 (enExample) |
| CN (1) | CN103998455B (enExample) |
| CA (1) | CA2852833A1 (enExample) |
| ES (1) | ES2702786T3 (enExample) |
| FR (1) | FR2981352B1 (enExample) |
| IN (1) | IN2014CN02870A (enExample) |
| SG (1) | SG11201401540WA (enExample) |
| WO (1) | WO2013057084A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2971509B1 (fr) * | 2011-02-16 | 2013-02-22 | Centre Nat Rech Scient | Procede de preparation de peptides par assemblage de multiples fragments peptidiques |
| BR112016000585A2 (pt) * | 2013-07-11 | 2018-03-20 | Novartis Ag | modificações quimioenzimáticas sítio-específicas de proteína |
| NL2027769B1 (en) * | 2021-03-18 | 2022-09-29 | Univ Delft Tech | C-terminal peptide modification |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT832096E (pt) | 1995-05-04 | 2002-01-30 | Scripps Research Inst | Sintese de proteinas atraves de ligacao quimica nativa |
| JP4358307B2 (ja) | 1996-12-24 | 2009-11-04 | ザ スクリップス リサーチ インスティテュート | 一般的化学結合 |
| EP1001968B1 (en) * | 1997-06-13 | 2004-12-22 | Gryphon Therapeutics, Inc. | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
| US6570040B2 (en) | 2000-03-16 | 2003-05-27 | The Regents Of The University Of California | Chemoselective ligation |
| AU6153001A (en) | 2000-05-12 | 2001-11-26 | Wisconsin Alumni Res Found | Ligation method and reagents to form an amide bond |
| WO2003042235A2 (en) | 2001-11-14 | 2003-05-22 | Geneprot, Inc. | Extended native chemical ligation of three or more peptide fragments |
| JP2008529969A (ja) * | 2004-10-26 | 2008-08-07 | ロンザ ア−ゲ− | 固相合成におけるｓ−アルキル−スルフェニル保護基 |
| CA2597490A1 (en) * | 2005-02-11 | 2006-08-17 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Solid-phase oligosaccharide tagging: a technique for manipulation of immobilized carbohydrates |
| US7667076B2 (en) | 2005-09-14 | 2010-02-23 | Regents Of The University Of California | Amide forming chemical ligation |
| FR2952058B1 (fr) * | 2009-10-29 | 2013-10-04 | Centre Nat Rech Scient | Procede de ligation native de polypeptides |
| EP2501711B1 (en) | 2009-11-16 | 2014-01-08 | Centre National De La Recherche Scientifique CNRS | Compounds and methods for purifying peptides produced by solid phase peptide synthesis |
-
2011
- 2011-10-17 FR FR1159348A patent/FR2981352B1/fr not_active Expired - Fee Related
-
2012
- 2012-10-16 CN CN201280062427.3A patent/CN103998455B/zh not_active Expired - Fee Related
- 2012-10-16 IN IN2870CHN2014 patent/IN2014CN02870A/en unknown
- 2012-10-16 ES ES12772951T patent/ES2702786T3/es active Active
- 2012-10-16 SG SG11201401540WA patent/SG11201401540WA/en unknown
- 2012-10-16 WO PCT/EP2012/070454 patent/WO2013057084A1/fr not_active Ceased
- 2012-10-16 EP EP12772951.5A patent/EP2768842B1/fr not_active Not-in-force
- 2012-10-16 JP JP2014536201A patent/JP6321542B2/ja active Active
- 2012-10-16 US US14/352,155 patent/US9206224B2/en not_active Expired - Fee Related
- 2012-10-16 CA CA2852833A patent/CA2852833A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6321542B2 (ja) | 2018-05-09 |
| CN103998455B (zh) | 2018-05-29 |
| US20140256879A1 (en) | 2014-09-11 |
| ES2702786T3 (es) | 2019-03-05 |
| FR2981352A1 (fr) | 2013-04-19 |
| WO2013057084A1 (fr) | 2013-04-25 |
| EP2768842B1 (fr) | 2018-07-25 |
| CN103998455A (zh) | 2014-08-20 |
| CA2852833A1 (fr) | 2013-04-25 |
| JP2014532075A (ja) | 2014-12-04 |
| EP2768842A1 (fr) | 2014-08-27 |
| SG11201401540WA (en) | 2014-06-27 |
| US9206224B2 (en) | 2015-12-08 |
| FR2981352B1 (fr) | 2015-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2017000552A1 (en) | Antibody constructs for msln and cd3. | |
| MX355416B (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| WO2014124334A3 (en) | Transthyretin antibodies and uses thereof | |
| MY161291A (en) | Antibody, kit and method for determination of amyloid peptides | |
| EP4282484A3 (en) | Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases | |
| WO2015061634A3 (en) | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders | |
| MX2018009304A (es) | Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. | |
| NZ700823A (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
| BR112013024213B8 (pt) | Método de fabricação de instrumento médico e instrumento médico | |
| PH12017500489A1 (en) | Human-derived anti-dipeptide repeats (dprs) antibody | |
| MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
| MX2016000393A (es) | Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana. | |
| EP2560681A4 (en) | USE OF TAU FOR MONITORING IMMUNOTHERAPY | |
| WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
| WO2015001013A3 (en) | Human anti-ifn-alpha antibodies | |
| WO2016023991A8 (de) | Verfahren zur mikrobiom-analyse | |
| WO2014091490A3 (en) | Diagnosis of autoimmune diseases using a specific antibody profile | |
| EP3696190A3 (en) | Methods | |
| WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
| SG10201907690TA (en) | Device and method for detecting target molecules | |
| EP3112867A4 (en) | Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit | |
| EA029703B9 (ru) | Новый аллерген из пыльцы амброзии и его применение | |
| MY192159A (en) | Method for detecting neutralizing antibodies against recombinant human insulin in human serum | |
| MX2015009726A (es) | Metodo para la prediccion de la aparicion de sintomas extrapiramidales (sep) inducidos por un tratamiento con antipsicoticos. |